First Eagle Value In Biotechnology Master Fund, Ltd.

Avg. Two Year Performance

328% Avg. Purchase Return

107% Compound

No sale track record

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	4%	26%	< 1%	81%	328%
Purchase Success Rate	2 of 2	1 of 2	1 of 2	2 of 2	2 of 2
Average Sale Return	--	--	--	--	--
Sale Success Rate	--	--	--	--	--

Aradigm Corp

Drugs » Biotechnology

10% Owner:

Holdings: 71.36M shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--